Inhibition of platelet aggregation may occur. Aggravation of psychiatric disorders, epilepsy or Parkinsonism may occur. Patients receiving long-term treatment should be periodically screened for renal and hepatic function and blood counts.
Skip to main content
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- Trade Name: Emflex (Merck)
- Indications: Osteoarthritis, rheumatoid arthritis, lower back pain, post-operative pain, inflammation, musculoskeletal disorders, psychoses
- Synonym: acemetacine; acemetacinum
- Class: Non-steroidal anti-inflammatory (NSAID)
- Half-life: <1.1 hours
- Clinically important, potentially hazardous interactions with:
ACE inhibitors, Anti-coagulants, Aspirin, Beta blockers, Beta-Carotene, Diflunisal, Furosemide, Haloperidol, Lithium, Methotrexate, Potassium sparing diuretics, Probenecid, Salicylates, Thiazide diuretics, Triamterene, Warfarin - Pregnancy: Contra-indicated in the third trimester of pregnancy
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
